Eli Lilly Acquires Centessa Pharmaceuticals for $6.3B in Sleep Disorder Focus
Eli Lilly is acquiring Centessa Pharmaceuticals for $6.3 billion, focusing on sleep and wakefulness disorder treatments. The deal reflects Lilly’s strategy to strengthen its portfolio amid international pricing and U.S. policy pressures.
· 66d ago
